Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Transpara

K-Number: K193229 · 2020-03-05

ApplicantScreenpoint Medical B.V.
Decision Date2020-03-05
Product CodeQDQ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Transpara is a medical device manufactured by Screenpoint Medical B.V.. It received FDA 510(k) clearance on 2020-03-05 under approval number K193229. The device is classified under product code QDQ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Transpara?

Transpara is a medical device that received FDA 510(k) clearance on 2020-03-05. It is manufactured by Screenpoint Medical B.V.. The 510(k) number is K193229.

When was Transpara approved by the FDA?

Transpara received FDA 510(k) clearance on 2020-03-05, under approval number K193229.

What company makes Transpara?

Transpara is manufactured by Screenpoint Medical B.V..

What is the FDA product code for Transpara?

The FDA product code for Transpara is QDQ.

Other Devices by Screenpoint Medical B.V.

K181704Transpara K192287Transpara K210404Transpara 1.7.0 K221347Transpara 1.7.2 K232096Transpara Density 1.0.0 K241831Transpara (2.1.0)

View all 7 devices →

Related Devices (Code: QDQ)

K182373PowerLook Tomo Detection V2 SoftwareIcad, Inc. K181704TransparaScreenpoint Medical B.V. K192287TransparaScreenpoint Medical B.V. K191994ProFound AI Software V2.1Icad, Inc. K201019Genius AI DetectionHologic, Inc. K192854MammoScreenTherapixel

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑